Skip to content

Characterization of the Gut Microbiota Composition and Activity After Three Weeks of Chitin-glucan Supplementation

Characterization of the Gut Microbiota Composition and Activity After Three Weeks of Chitin-glucan Supplementation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03505177
Enrollment
17
Registered
2018-04-23
Start date
2018-04-22
Completion date
2018-05-18
Last updated
2018-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The aim of this research study is to characterize gut microbiota composition and activity after a daily supplementation of 4.5 g of chitin-glucan during 3 weeks. For this purpose, a monocentric longitudinal intervention study without control will be performed. Fecal microbiota composition and fecal concentrations of gut microbiota-derived metabolites (bile acids, conjugated-polyunsaturated fatty acids and short-chain fatty acids) will be measured. In addition, during ten hours following the ingestion of a test meal rich in fibers, the kinetic of production of H2, methane and volatile compounds exhaled from breath will be evaluated.

Interventions

DIETARY_SUPPLEMENTChitin-glucan fiber

4.5g per day of chitin-glucan during 3 weeks

Sponsors

Nathalie Delzenne
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Supplementation during 3 weeks with 4.5g of chitin-glucan

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Woman or man, aged of 18 to 40 years * Body mass index (BMI) between 18 and 25 kg/m2 * In good general health as evidenced by medical history and physical examination * Non-smoker * Caucasian * H2 - producer * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study

Exclusion criteria

* Subjects presenting gastro-intestinal disorders such as ulcers, diverticulitis and inflammatory bowel diseases * Subject presenting allergy or food intolerance (lactose, gluten,…) * Subjects with psychiatric problems and/or using antipsychotics * Current or recent (\< 4 weeks) intake of antibiotic, probiotic, prebiotic, fiber supplement, and/or any product modulating gut transit * Feeding particular diet such as vegetarian diet or hyper protein diet * Chronic intake of drug, excepted contraceptive drug * Pregnant or lactating woman or woman who did not use highly effective contraception * Subjects who drink more than 3 glasses of alcohol per day (\> 30 g of alcohol per day) * Subjects having participated to another clinical trial two weeks before the screening test visit * Subjects presenting an allergy or intolerance to one component of the product tested

Design outcomes

Primary

MeasureTime frameDescription
Gut microbiota compositionDifference between day 0 and day 21Illumina sequencing of 16SrDNA

Secondary

MeasureTime frameDescription
Fecal bile acidsDifference between day 0 and day 21Gas chromatography-mass spectrometry (GC/MS)
Fecal conjugated-linoleic acidsDifference between day 0 and day 21Gas chromatography using Flame ionization detector (GC- FID)
Exhaled acetateDifference between day 0 and day 21Gas chromatography using Flame ionization detector (GC- FID) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Exhaled propionateDifference between day 0 and day 21Gas chromatography using Flame ionization detector (GC- FID) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Exhaled butyrateDifference between day 0 and day 21Gas chromatography using Flame ionization detector (GC- FID) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Exhaled C2Difference between day 0 and day 21Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Exhaled CO2Difference between day 0 and day 21Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Exhaled H2SDifference between day 0 and day 21Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Exhaled O2Difference between day 0 and day 21Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Exhaled N2Difference between day 0 and day 21Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Exhaled CH4Difference between day 0 and day 21Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Fecal short-chain fatty acidsDifference between day 0 and day 21Gas chromatography using Flame ionization detector (GC- FID)
Exhaled H2Difference between day 0 and day 21Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Exhaled volatile compoundsDifference between day 0 and day 21Gas chromatography using selected ion flow tube mass spectrometry - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)
Gastro-intestinal symptom - discomfort3 weeks100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - every day during the chitin-glucan supplementation
Gastro-intestinal symptom - nausea3 weeks100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - every day during the chitin-glucan supplementation
Gastro-intestinal symptom - bloating3 weeks100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - every day during the chitin-glucan supplementation
Gastro-intestinal symptom - flatulences3 weeks100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - every day during the chitin-glucan supplementation
Gastro-intestinal symptom - gastrointestinal reflux3 weeks100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - every day during the chitin-glucan supplementation
Gastro-intestinal symptom - cramps3 weeks100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - every day during the chitin-glucan supplementation
Gastro-intestinal symptom - rumbling3 weeks100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - every day during the chitin-glucan supplementation
Gastro-intestinal symptom - burps3 weeks100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - every day during the chitin-glucan supplementation
Exhaled CODifference between day 0 and day 21Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026